Literature DB >> 23960732

Development of a capillary electrophoresis method for the determination of orphenadrine citrate in tablets in the presence of paracetamol.

Dana N Haj-Ali1, Imad I Hamdan.   

Abstract

A validated method using capillary electrophoresis was developed, for the determination of orphenadrine citrate in its tablet formulations, in the presence of paracetamol. The method employs a running buffer of 30 mM pentane sulfonate sodium, dissolved in 20 mM MOPS buffer pH 7.7. Samples were injected using hydrodynamic sample injection mode (25 mbar, for 25 s), using positive polarity of 25 kV, at a constant temperature of 30 °C. Samples of orphenadrine citrate alone or in mixture solutions with paracetamol were exposed to various degradation conditions, and were electrophoresed using the recommended condition. The method was found to be specific, linear (r (2) = 0.994), precise, accurate, and robust, with an LOQ of 0.02 mg/mL. The proposed method was successfully applied for measurement of the percentage per label of orphenadrine citrate in commercially available tablets.

Entities:  

Keywords:  Capillary electrophoresis; Orphinadrine citrate; Paracetamol

Year:  2010        PMID: 23960732      PMCID: PMC3730974          DOI: 10.1016/j.jsps.2010.07.007

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  10 in total

1.  Pharmacokinetic study of orphenadrine using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS).

Authors:  Soo-Youn Lee; Hyeon Ju Oh; Jong Won Kim; Yoon Gyoon Kim; Chul Jin Moon; Eun Hee Lee
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-04-03       Impact factor: 3.205

2.  Utility of NBD-Cl for the spectrophotometric determination of some skeletal muscle relaxant and antihistaminic drugs.

Authors:  Hanaa M Saleh; Magda M El-Henawee; Gamal H Ragab; Soad S Abd El-Hay
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2006-10-14       Impact factor: 4.098

3.  Spectrophotometric determination of phenylephrine HCl and orphenadrine citrate in pure and in dosage forms.

Authors:  S A Shama
Journal:  J Pharm Biomed Anal       Date:  2002-11-07       Impact factor: 3.935

4.  Determination of nanogram quantities of diphenhydramine and orphenadrine in human plasma using gas-liquid chromatography.

Authors:  W Bilzer; U Gundert-Remy
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

5.  Clinical efficacy of antihistaminics as analgesics.

Authors:  Martha M Rumore; David A Schlichting
Journal:  Pain       Date:  1986-04       Impact factor: 6.961

Review 6.  Centrally acting skeletal muscle relaxants and associated drugs.

Authors:  H J Waldman
Journal:  J Pain Symptom Manage       Date:  1994-10       Impact factor: 3.612

7.  Sensitive and specific gas chromatographic and extraction method for the determination of orphenadrine in human body fluids.

Authors:  J J Labout; C T Thijssen; W Hespe
Journal:  J Chromatogr       Date:  1977-12-01

8.  Quantitative determination of diphenhydramine and orphenadrine in human serum by capillary gas chromatography.

Authors:  D Lutz; W Gielsdorf; H Jaeger
Journal:  J Clin Chem Clin Biochem       Date:  1983-10

9.  Simple and rapid GLC method for the determination of orphenadrine in human plasma.

Authors:  M Contin; R Riva; F Albani; A Baruzzi
Journal:  Biomed Chromatogr       Date:  1987       Impact factor: 1.902

10.  A double-blind comparison in general practice of a combination tablet containing orphenadrine citrate and paracetamol ('Norgesic') with paracetamol alone.

Authors:  B W McGuinness
Journal:  J Int Med Res       Date:  1983       Impact factor: 1.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.